Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds.

ABSTRACT:

Objective

Diabetes technology is available and its efficacy and safety have been demonstrated; however, there is little evidence as to how this technology is being utilized and its effectiveness in vulnerable populations. This study evaluated differences in outcomes for young adults in the United States (U.S.) from lower socioeconomic (SES) backgrounds with type 1 diabetes (T1D) managed on continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) or fixed-dose insulin (FDI).

Research design methods and participants

Utilizing the Optum® de-identified Electronic Health Record data set between 2008 and 2018 to perform a retrospective, cohort study, we identified 805 subjects with T1D aged 18-30 years with Medicaid. We evaluated median difference in

SUBMITTER: McKee AM 

PROVIDER: S-EPMC8279595 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature